| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | Innate Immunotherapeutics | Feb 5, 2018 |
This page tracks congressional stock trading activity in INNL in the company_delisted sector. Disclosed Capitol has indexed 1 disclosed congressional trade involving INNL. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of March 2018 — Disclosed Capitol has tracked 1 disclosed congressional trades in INNL — 1 sells with no recorded buys — led by Chris Collins (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| 2018-02-05 | Chris Collins | R | Sale | $15,001 - $50,000 |
Across the 1 disclosed congressional trade in INNL, members of Congress have reported 0 buys and 1 sell.